Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERCOP: Interferon-β-1a in COVID-19
NCT04449380Phase 2Terminated
- Start
- Nov 2020
- Primary completion
- Mar 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1a in coronavirus disease 2019 (COVID-19). Started Nov 2020; status: terminated.
02
Drugs
interferon beta-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04449380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04449380.